2-chloro-5-(1-pyrrolidinylmethyl)pyridine, 95.0%, 5g

TERT-BUTYL 3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 250mg

4-Methyltetrahydro-2H-pyran-4-amine hydrochloride, 95.0%, 250mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-thioxanthen-2-ylcarbamate, 95.0%, 100mg

4-Bromo-3-methoxy-5-methylthiophene-2-carboxylic acid, 95%, 100mg

5-Chloronicotinonitrile, 98.0%, 25g

1-(propan-2-yl)-1H-indole-2-carboxylic acid, >95%, 1g

Graphene Nanoplatelets 2-10nm(thick), 5micro m(wide)5g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

4-Iodo-3-methoxypyridine, 97%, 1g

Diethyl 3-(trifluoromethyl)benzylphosphonate, 1g

4-Aminoquinoline, 95.0%, 1g

3-Pentanimine, 2,2,4,4-tetramethyl-, 1g